A new test developed by University of Michigan researchers could help patients with brain cancer and their care teams make more informed treatment decisions. By temporarily opening the blood brain barrier, the test evaluates how well chemotherapy works against glioblastoma. Researchers say the approach could open new paths for treating this aggressive and often fatal disease. Read more about the study in this research spotlight from Michigan News.
